Objective: To evaluate whether quantitative measures from magnetic resonance imaging (MRI) performed in hypothermia-treated encephalopathic newborns can differentiate patients with unfavorable neurological outcome.
Introduction
Neonatal encephalopathy occurs in 2 to 3 per 1000 live births with a higher occurrence rate in lesser developed countries. It remains an important cause of mortality and morbidity in the newborn period, associated with a 10 to 75% risk of death and a 30 to 100% risk of major neurological sequelae in survivors for moderate and severe encephalopathy, respectively. 1, 2 Hypothermia has been increasingly adopted as therapy for babies with neonatal encephalopathy and has been shown to reduce mortality and disability after asphyxia or depression at birth. 3, 4 The early and accurate assessment of severity of brain injury (and risk for subsequent neurodevelopmental disability) in this at-risk population is important for appropriate parental counseling and identification of patients who might benefit most from early intervention services. Qualitative and quantitative assessment of magnetic resonance imaging (MRI) of the brain has been shown to have prognostic significance for neurodevelopmental outcome in depressed neonates in the 'pre-cooling era'. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Few reports have described manifestation and evolution of MRI evidence of brain injury in patients who are treated with hypothermia.
Similarly, evaluation of quantitative methods to assess MRI information has not been assessed in the hypothermia-treated population.
The aim of this study is to evaluate quantitative assessment of brain MRIs performed in infants with neonatal encephalopathy treated with whole-body hypothermia. Apparent diffusion coefficients (ADCs), T1 and T2 intensity ratios measured from the basal ganglia and thalamus were evaluated for their ability to predict neurological deficit at discharge and presence of cerebral palsy (CP) in this high-risk population. These locations were chosen on the basis of reports showing that (1) these are major regions affected in asphyxiated neonates [19] [20] [21] and (2) that injury to these regions are associated with adverse neuromotor outcome. 5, 21, 22 Methods Study population All infants admitted to our level IIIC neonatal intensive care unit with moderate or severe encephalopathy are treated with wholebody cooling according to the National Institute of Child Health and Human Development protocol described by Shankaran et al. Infants meeting established criteria 3 are cooled to an esophageal temperature of 33.5 1C for 72 h, and then rewarmed at þ 0.5 1C per hour to 36.5 1C through a servo-controlled cooling blanket (Blanketrol II Hyper-Hypothermia System, Cincinnati Sub-Zero, Cincinnati, OH, USA). Infants treated with hypothermia for neonatal encephalopathy between May 2006 and July 2008, who received a brain MRI within the first 2 weeks of life, were included in the study. Institutional review board approval was obtained for this retrospective study.
Data collection and outcome measures
Clinical and demographic data were collected from the medical records of the study population. Classification of encephalopathy grade at presentation was determined according to the definitions of moderate and severe encephalopathy used in the National Institute of Child Health and Human Development trial. 3 In addition, documentation of clinical seizures (that is, frank bicycling or rowing movements, ocular deviation, lip smacking or focal or generalized tonic-clonic movements witnessed by a reliable observer) was noted. Electrographic seizures detected by continuous electroencephalographic monitoring (performed as soon as possible after initiation of hypothermia and continued through rewarming) were also noted. However, because several patients had clinical events that required antiepileptic therapy before initiation of electroencephalographic monitoring, clinical seizures were used as a covariate in the analysis to capture all patients who may have had ictal events.
The last documented neurological exam performed by a child neurologist before discharge was reviewed. Patients were classified as having unfavorable outcome if they had severe neurological deficit at the time of hospital discharge. Severe neurological deficit was defined as major abnormalities in consciousness (vegetative state), severe hyper or hypotonia, sensory deficit (absent visual fixation or moderate-to-profound bilateral hearing loss confirmed by brainstem auditory evoked response with threshold of >40 dB) or absent gag/suck/feeding autonomy. In addition, in patients for whom follow-up information was available through at least 9 months of age, diagnosis of CP by a child neurologist or severe motor impairment (Bayley Scales of Psychomotor Developmental Index of <50) by a developmental psychologist was noted.
MRI analysis
All patients treated with hypothermia underwent routine MRI of the brain in the second week of life (target 7 to 10 days) if they were clinically stable. This standardized imaging time was incorporated into our hypothermia protocol because it enables infants who have recovered in this timeframe to be off respiratory support and feeding, allowing for effective immobilization and MRI acquisition without the use of sedation. Infants who remained critically ill requiring mechanical ventilation were transported to the MRI scanner through an MR-compatible incubator with integrated ventilator (Advanced Imaging Research, Cleveland, OH, USA). MRI scans were performed on a 1.5 T scanner (Signa: General Electric, Milwaukee, WI, USA). Standard whole-brain imaging protocol included axial and sagittal T1-weighted images, axial fast spin-echo T2/proton density double-echo acquisition and coronal T2 images obtained with field of view of 18 to 22 (depending on head size) and 4 mm slice thickness, 0 gap. Echo planar diffusion-weighted images (three directions, b ¼ 0 and 1000 s mm -2 , TR/TE 800 to 10 000 and 80 to 90 ms; slice thickness 5 mm; no intersection gap; 128 Â 160 matrix) were acquired. ADC maps were generated using General Electric software (Functool; General Electric).
Quantitative measurements were performed using the General Electric Advantage Windows workstation by placing regions of interest (ROIs) (each measuring 48 to 50 mm 2 ) in the putamen and ventrolateral thalamus at the level of the foramen of Monro (Figure 1 ). T1 and T2 intensity values were normalized to ocular vitreous signal intensity on the same sequence and analyzed as ratios to account for differences in scaling, coil loading or other acquisition conditions that may variably affect signal intensity. 8 ADC values were obtained by tracing ROIs on the echo planar imaging T2-weighted images (that is, the b ¼ 0 echo planar diffusion-weighted images) acquired as part of the echo planar diffusion-weighted image sequence, which were overlaid on the corresponding ADC map. Measurements were performed by a single investigator (AM) who was blinded to the patients' clinical information. ROI placement was reviewed by a neuroradiologist (NK) who was similarly blinded to patient history and outcome category. ROI measurements of the corresponding anatomic structures from both the left and right hemispheres were averaged, and a representative ADC, T1 and T2 value was obtained for each anatomic region. Qualitative assessment was also performed by the same neuroradiologist, with classification of MRI evidence of injury in these two brain regions as present or absent.
Statistical analysis
Univariate analysis with independent samples t-test or MannWhitney U-test for parametric and nonparametric continuous variables, respectively, and w 2 test for categorical variables was performed to evaluate differences between outcome category groups. Variables that were significantly different between groups and those that were related to severity at presentation were included as covariates in a logistic regression model. Death or presence of severe neurological deficit was the primary dependent variable. Death or presence of severe motor impairment/CP was similarly analyzed as a secondary outcome in the subset of patients for whom follow-up information was available. Because the primary independent variables (MRI ADC and T1/T2 intensity ratios) were highly collinear, a separate logistic regression model was estimated for each variable that was significant in the univariate analysis. Owing to the small sample size, exact logistic regression was used to estimate odds ratios (ORs). 23 ORs were estimated for a 0.1-unit change in the primary independent variable. For significant MRI variables, receiver operating curve analysis was used to determine optimal cutoff values and corresponding sensitivity and specificity for prediction of unfavorable outcome. For comparison, sensitivity and specificity calculations were also performed for the presence of MRI signal abnormality based on qualitative assessment. Statistical analysis was performed with SPSS 12.0 for Windows (SPSS, Chicago, IL, USA) and STATA version 10 for Windows (StataCorp, College Station, TX, USA) software.
Results
A total of 64 patients were treated with hypothermia for neonatal encephalopathy during the study period. Of the total, 17 patients did not have MR imaging available for analysis because they either died before imaging was performed (n ¼ 10), did not receive imaging before discharge or were transferred to another institution (n ¼ 3), received later imaging because of clinical instability (n ¼ 3) or had images of poor quality secondary to motion artifact (n ¼ 1). The remaining 47 patients received MRI imaging of the brain performed at a median age of 7 days (range 5 to 12 days) and were included in this report. As seven patients did not have axial diffusion sequences performed, ADC values were analyzed for 40 of 47 patients.
The demographic and clinical characteristics of the study group are presented in Table 1 . Of the 27 patients with reported clinical seizures, 10 patients had seizures on electroencephalographic monitoring during their hypothermia course. In addition, three patients had subclinical seizures. One patient died and eight patients had severe neurological deficit at discharge. Follow-up information through at least 9 months of age was available for 26 of 47 patients. The patients lost to follow-up did not differ from the study group with regard to birth weight, gestational age, gender, Apgar scores, encephalopathy grade or proportion with clinical seizures. Twelve patients were diagnosed with spastic diplegic or quadriplegic CP and/or had Bayley Psychomotor Developmental Index of <50. Characteristics of the patients with unfavorable outcome at discharge and/or follow-up are described in Table 2 . Patients who died or had severe neurological deficit were of older gestational age, had a higher rate of clinical seizures, lower Apgar scores at 10 min of life and a trend toward higher rate of severe encephalopathy when compared with infants who were assessed to be normal or having mild deficits at discharge (Table 1) .
ADC and T1 intensity ratio values were similar between outcome groups (Table 3 ). In contrast, T2 signal intensity ratios in both the basal ganglia and thalamus were significantly higher in the death/ severe deficit group compared with the group with favorable outcome at discharge (Figure 2a) . Similarly, T2 ratios were higher in patients with CP/severe motor deficit compared with those with favorable outcome at follow-up (Figure 2b) . In logistic regression analysis controlling for the effects of gestational age, seizures and Apgar score at 10 min, T2 ratios in the thalamus (OR 3.76, 95% confidence interval 1.09 to þ infinity, P ¼ 0.035) and basal ganglia (OR 3.50, 95% confidence interval 1.08 to þ infinity, P ¼ 0.035) were independently associated with increased odds of unfavorable outcome at discharge. Similarly, after controlling for gestational age and presence of seizures, T2 ratios in the thalamus were associated with increased odds of CP/severe motor deficit at follow-up (OR 5.41, 95% confidence interval 1.30 to 38.4, P ¼ 0.016). T2 ratios in the basal ganglia were not significantly associated with CP/severe motor deficit after adjusting for covariates. Receiver operating curve analysis was performed to determine optimal cutoff values for T2 measurements in the two brain ROIs that had the highest sensitivity for predicting unfavorable outcome at discharge (Figure 3 ). Using these cutoff values, the sensitivity and specificity of T2 ratio measurement in predicting unfavorable outcome at discharge was comparable to, but not better than, qualitative grading by an experienced neuroradiologist (Table 4) .
Discussion
This study shows that MRI quantitative assessment can be useful in predicting outcome for patients with moderate-to-severe neonatal encephalopathy treated with hypothermia. Although not a replacement for interpretation by an experienced neuroradiologist, this tool can be used as an objective adjunct to qualitative reading. This may be useful especially at centers that do not have pediatric neuroradiologists who are experienced with the developmental changes and variable appearance of injury that hallmark the challenges of neonatal MRI interpretation. Intensity ratio measurement offers a method to evaluate standard (T1 and T2) sequences that historically have been qualitatively interpreted as opposed to the more easily quantitated diffusion images. These measurements are also easily performed on a standard workstation and require no additional sequence acquisition or software.
The limitations of this retrospective study include the use of a short-term (discharge) outcome variable and lack of complete follow-up information on this cohort. All but one patient assessed to have severe neurological deficit at discharge were confirmed to have significant impairment at later evaluation, suggesting that patients with severe neurological deficits at discharge, as defined in this study, will likely go on to have neurodevelopmental impairment. However, given that there were four patients diagnosed with CP/severe motor impairment at follow-up who were not categorized in the unfavorable outcome group at discharge, it is clear that neurological assessment of these patients at discharge is not a comprehensive surrogate for long-term follow-up. That a significant difference in T2 measurements was similarly showed in the patients retained in follow-up further supports the use of this tool in predicting outcome, although it is recognized that these data may be limited by selection bias. It is noteworthy that 13 of the 21 patients lost to follow-up were evaluated at least once after discharge before loss of contact and none of these patients were found to have significant impairments at these visits. This information, combined with the knowledge that severely impaired children are more likely to continue follow-up, provide some measure of confidence that those children with significant impairment were identified and included in this analysis. This study shows that MRI adds prognostic information even when controlling for factors reflecting severity at presentation. This further supports its already widespread use in the routine evaluation of encephalopathic newborns after cooling. Early clinical (for example, Apgar scores, seizures and encephalopathy grade) and physiological (for example, presenting pH and base deficit and initial amplitude-integrated electroencephalographic background) indicators, although associated with adverse outcome in some series, have not been able to adequately identify all patients who will go on to have persistent neurological deficits. 22,24 -29 It is clear that no single variable will have 100% accuracy in predicting outcome. Thus, combinations of variables with additive prognostic information are needed to improve overall ability to predict death and disability after perinatal depression. Such information is essential for counseling families and directing intervention services, especially in areas in which resources for such services are limited. Objective and quantifiable predictors of outcome, such as quantitative MRI measures, are especially valuable as they can be mathematically combined to potentially improve sensitivity, specificity and overall accuracy of prediction.
Our findings of differences in T2 measurements, but not in T1 or ADC measurements, are recognized to be largely related to timing of MRI in the study population. Changes in intensity on both T1 and T2 evolve in the several days to weeks after injury. Initially, there is T1 and T2 prolongation, followed by T1 shortening at 2 to 3 days and T2 shortening by day 6. 30 Thus, depending on the time elapsed from injury, the area of interest may appear normal, hypo-or hyperintense. Similarly, ADC values are initially reduced as diffusion is restricted acutely by cellular edema, then returns to normal values at 5 to 10 days (that is, 'pseudonormalization') before increasing further with cell death. 31, 32 The effects of hypothermia on this evolution of MRI evidence of brain injury is not known. Thus, when using quantitative MRI methods, it is essential to use standard timing of MR imaging to be able to compare gradation of intensity. The target of routine imaging at 7 to 10 days of life in the hypothermia-treated population facilitates the ease of MRI acquisition without the use of sedation as infants may be off respiratory support, feeding and can be immobilized effectively. Unless MRI information is being used to direct care in severe cases, imaging solely for prognostic purposes and parental counseling can be adequately performed in the second week of life, without the added stress of transporting the acutely ill child to the MRI scanner. Our results suggest that this timing may ideally capture hyperintensity on T2 sequences while early diffusion restriction may have normalized and T1 evolution may be in process or more variable. Earlier or later scanning would likely yield different results.
This concept of standardized timing of MR imaging explains why our results differ from others who have described the utility of ADC measurements and, alternatively, the lack of predictive ability of intensity ratios. Several investigators have reported prognostic utility of ADC values measured in various regions, including basal ganglia, 13 subcortical frontal and parietal white matter 14 and posterior limb of the internal capsule. 14, 15 Others, similar to us, have found no association with neurologic outcome. 33, 34 These conflicting findings may be attributable to the limited sample size of the studies (n ¼ 10 to 30) and variable timing of MRI in the patient cohorts (ranging from 1 to 18 days). The fact that we did not find decreased ADC values, given that most infants were imaged a week after their presumed perinatal insult, is not surprising. However, one may have expected to see increased ADC values (associated with a highly diffusing extracellular space around cellular loss) in the more severely injured infants. It remains unknown whether the similar ADC values between outcome groups is purely a function of timing of imaging acquisition or whether hypothermia may have some role in attenuating the changes in intra and extracellular matrix that affects diffusion properties. This question may only be answered by serial imaging studies in this population.
The significance of T2 intensity ratio measurements found in our study differs from the findings of the group that first proposed this methodology. 8 Coskun et al. 8 reported that only quantitative MRI measurements in the anterior watershed area showed significant association with cognitive outcome. However, T2 thalamic measurements were associated with lower 12-month Bayley Mental Development Index on univariate analysis and there was a trend toward an association between T2 basal ganglia measurements with abnormal neurological examination. The researchers postulated that their inability to show an association between quantitative MR measurements and outcome may have been due in part to the voxel size (40 mm 2 ) that may have missed the region of injury and variability of scan time. A slightly larger voxel size (50 mm 2 ) was used in this study to increase sensitivity for including regions of signal abnormality while still remaining within the boundary of the anatomic ROI. This minor difference in methodology is likely less important than the standardization of imaging time and exclusion of infants that were scanned outside of the first 2 weeks of life. This method allowed us to evaluate infants at comparable stages of injury evolution and enabled the use of T2 intensity as an indicator of severity. Future prospective studies are needed to verify these findings and should include measurements from healthy control infants for comparison that were not possible in this retrospective study.
Conclusion
Basal ganglia and thalamic T2 signal intensity ratios measured on brain MRI performed in hypothermia-treated encephalopathic newborns are predictive of death or severe neurological deficit at discharge and CP/severe motor impairment at 9-month follow-up. It is important to confirm these findings in prospectively evaluated cohorts that are followed long term. It is equally important to determine whether injuries to other brain regions (for example, cortical and frontal white matter) are similarly predictive of long-term cognitive outcome.
